addiction

Bayer Heroin opioids

First Opinion

What an 1890s opioid epidemic can teach us about ending addiction today

By Haider J. Warraich

Christina Nolan- VT AG

Business

Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?

By Andrew Joseph

advertisement

buprenorphine

First Opinion

A government database is supposed to help people seeking treatment for opioid addiction. It often doesn’t

By Lila Flavin and J. Wesley Boyd

advertisement

Oxycontin purdue photo illo

Health

Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show

By Andrew Joseph and Shraddha Chakradhar

Sound wave

Health Tech

Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders

First Opinion

Addiction treatment is broken. Here’s what it should look like

By William Stauffer

Methadone clinic

Health

This mental health advocate wants to make addiction and behavioral health a 2020 election issue

advertisement

Hospital Painkiller

First Opinion

A hospital staffer diverted drugs, which gave me hepatitis C. That happens more often than you think

By Lauren Lollini

advertisement

Opioid photo illustration

Health

National Academies outlines opioid guidelines, aiming to make approach to prescribing more consistent

By Andrew Joseph

Suboxone script

First Opinion

Orphan Drug Act’s ‘nonprofitability’ loophole needs to be closed

By Diane Dorman

Vivitrol Opioids

Politics

FDA blasts Alkermes for underselling the risks of opioid addiction drug Vivitrol

Substance abuse treatment center bed

First Opinion

Mental health and addiction care are poorly covered by insurance networks

By Patrick J. Kennedy

Opioids Sacklers Tufts

Health

Tufts will scour Sackler name from its medical campus, in rebuff of family that controls Purdue Pharma

By Andrew Joseph

OC Phases

Exclusive

The history of OxyContin, told through unsealed Purdue documents

By Shraddha Chakradhar and Casey Ross

Purdue docs

Exclusive

Purdue’s Richard Sackler proposed plan to play down OxyContin risks, and wanted drug maker feared ‘like a tiger,’ files show

Aerial view Huntington, West Virginia

First Opinion

The view from West Virginia: the end of HIV transmission is a distant dream

By Judith Feinberg

Buprenorphine as Methadone Alternative

First Opinion

Changing emergency doctors’ behaviors to promote wider use of medication for opioid use disorder

By Alister Martin and Ted Robertson

Oxy with newsprint

Pharma

How Purdue planted its ‘anti-story’ and delayed the reckoning for its role in the opioid epidemic

By David Armstrong — ProPublica

Paul Tonko

Politics

A new bill would let more doctors prescribe addiction treatments without waiting for insurers’ permission

Off the Charts

Off the Charts

When it comes to health care, nothing is nonpartisan. Melania Trump’s visit to a Boston hospital harms patients and providers

By Jennifer Adaeze Okwerekwu

Opioid pills

Health

With a new guide to tapering opioids, federal health officials seek a balanced approach to prescribing

By Andrew Joseph

Sesame Street addiction 02

Health

‘Sesame Street’ launches new initiative to help explain parental addiction to kids

By Shraddha Chakradhar

Booneville, Kentucky

First Opinion

Beyond the Sacklers: Free-trade policies contributed to the opioid epidemic

By Adam Dean and Simeon Kimmel

Purdue Pharma headquarters

Business

Purdue Pharma filed for bankruptcy. What does it mean for lawsuits against the opioid manufacturer?

By Andrew Joseph

Purdue Pharma headquarters

Business

Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy

By Andrew Joseph

TOBACCO TRIAL

Pharma

Historians push to create public archive of documents from massive opioid litigation

By Andrew Joseph

PHILLIP MORRIS HEADQUARTERS

First Opinion

Don’t let the opioid settlement fritter away funds like the tobacco settlement did

By Kathleen T. Brady

Purdue Pharma headquarters

Pharma

OxyContin maker Purdue Pharma agrees to tentative settlement in opioid lawsuits

By Associated Press

Purdue headquarters in shadow

Health

Purdue Pharma touts data that downplay its role in the opioid epidemic, new analysis shows

By David Armstrong and Jeff Ernsthausen — ProPublica